Réussite business : Jean-Louis Dasseux, la formule du succès
Cerenis Therapeutics, la start-up biotech qui révolutionne l'anti-cholestérol, entre en bourse
Cerenis Therapeutics se lance en Bourse: Jean-Louis Dasseux – 12/03 sur Orange Vidéos
Le Club Éco. Jean-Louis Dasseux, Cerenis Therapeutics : "Un marché potentiel de 35 milliards de dollars"
Cerenis Therapeutics announces new Board members
PR Cerenis July 2010 EN
Cerenis Therapeutics CEO and key executive team | Craft.co
Cerenis Therapeutics, des thérapies pour lutter contre les maladies cardio-vasculaires - ladepeche.fr
Cerenis respecte son plan de marche» | Le Revenu
Cerenis Therapeutics appoints Dr. Richard Pasternak as Chairman
Cerenis Appoints Non-Executive Director, CMO - CBS Detroit
Cerenis conserve son avance dans le HDL-mimétique | Le Revenu
Cerenis Therapeutics se lance en Bourse: Jean-Louis Dasseux – 12/03 sur Orange Vidéos
Long Hydrocarbon Chain Keto Diols and Diacids that Favorably Alter Lipid Disorders in Vivo | Journal of Medicinal Chemistry
Jean-Louis Dasseux, le cerveau de Cerenis - ladepeche.fr
Partnership explores using HDL as a tool for delivering drugs - Newsroom
HDL mimetic CER-001 targets atherosclerotic plaques in patients Kang He Zheng, Fleur M. van der Valk, Loek P. Smits, Mara Sandberg, Jean-Louis Dasseux, - ppt download
Finding The Right CRO For Rare Disease Trials
PDF) Erratum to “α-Cycloalkyl-substituted ω-keto-dicarboxylic acids as lipid regulating agents” | Jean-Louis Dasseux - Academia.edu
Dr. Jean-Louis Dasseux is the founder of Cerenis and one of the world's leading experts in lipid metabolism, lipid-protein int
CER-001: Analysis of clinical results to be presented at the American Heart Association Scientific Congress, on November 9, 201
Results of the CARAT Study - ppt download
CERENIS THERAPEUTICS - Interview de Jean-Louis DASSEUX, Fondateur et Directeur général - YouTube
